Solid Tumors, Metastasis & Therapy Resistance

Hematopoietic Stem Cells and Leukemia

Stem Cells and Tumor Microenvironment

HI-STEM Group Leaders

previous arrow
next arrow
PlayPause
Slider
NSGS mouse xenotransplanted with CD34+ cells from the corresponding MDS patient

Medyouf, H., Mossner, M., Jann, J.C., Nolte, F., Raffel, S., Herrmann, C., Lier, A., Eisen, C., Nowak, V., Zens, B., Mudder, K., Klein, C., Oblander, J., Fey, S., Vogler, J., Fabarius, A., Riedl, E., Roehl, H., Kohlmann, A., Staller, M., Haferlach, C., Muller, N., John, T., Platzbecker, U., Metzgeroth, G., Hofmann, W.K., Trumpp, A., & Nowak, D. (2014). Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell, 14(6), 824-837. doi: 10.1016/j.stem.2014.02.014

Links and further information

Pubmed | Read at Publisher
DKFZ Press Release (english)
DKFZ Pressemitteilung (deutsch)